Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Labcorp
LH
$25.8B
| $96.1M | 0.05% |
673,262
-33,995
| -5% | -$4.7M |
|
|
SUM
327
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $95.5M | 0.05% |
6,042,842
-1,106,477
| -15% | -$15.9M |
|
328
Teladoc Health
TDOC
$1.69B
| $95.4M | 0.05% |
499,683
+22,712
| +5% | +$3.98M |
|
329
Keysight
KEYS
$52.2B
| $95.2M | 0.05% |
944,778
-411,811
| -30% | -$40.4M |
|
330
Ciena
CIEN
$49.6B
| $95.1M | 0.05% |
1,756,479
+95,414
| +6% | +$4.74M |
|
331
Agilent Technologies
A
$39.7B
| $94.6M | 0.05% |
1,070,076
+485,638
| +83% | +$39.8M |
|
332
Pultegroup
PHM
$25.7B
| $94.4M | 0.05% |
2,774,960
-1,260,847
| -31% | -$37.9M |
|
333
Icon
ICLR
$13.9B
| $94.1M | 0.05% |
558,893
+118,044
| +27% | +$18.6M |
|
334
Chemed
CHE
$6.87B
| $94.1M | 0.05% |
208,566
+78,265
| +60% | +$34.9M |
|
|
SPLK
335
DELISTED
Splunk Inc
SPLK
| $94.1M | 0.05% |
473,531
+373,387
| +373% | +$59.1M |
|
336
Camden Property Trust
CPT
$11.4B
| $93.5M | 0.05% |
1,024,979
-291,556
| -22% | -$25.8M |
|
337
Carter's
CRI
$1.45B
| $92.9M | 0.05% |
1,151,077
-141,052
| -11% | -$11.2M |
|
338
PTC Therapeutics
PTCT
$6.25B
| $92.2M | 0.05% |
1,816,811
+47,054
| +3% | +$2.31M |
|
339
Goldman Sachs
GS
$305B
| $91.9M | 0.05% |
465,289
+9,121
| +2% | +$1.71M |
|
340
Wolfspeed
WOLF
$1.14B
| $91.4M | 0.05% |
1,544,032
-133,763
| -8% | -$6.44M |
|
341
Rockwell Automation
ROK
$52.4B
| $91.2M | 0.05% |
428,014
+20,509
| +5% | +$3.97M |
|
342
General Motors
GM
$81.7B
| $90.6M | 0.05% |
3,582,929
-4,514,868
| -56% | -$110M |
|
343
Cable One
CABO
$249M
| $90.5M | 0.05% |
50,990
-2,071
| -4% | -$3.71M |
|
344
Collegium Pharmaceutical
COLL
$1.16B
| $89.9M | 0.05% |
5,136,485
+32,519
| +0.6% | +$637K |
|
345
H.B. Fuller
FUL
$3.07B
| $89.4M | 0.05% |
2,005,149
-142,891
| -7% | -$5.19M |
|
346
Yext
YEXT
$564M
| $86.9M | 0.05% |
5,234,312
-373,480
| -7% | -$5.24M |
|
347
WIX.com
WIX
$2.45B
| $85.6M | 0.05% |
334,130
+23,010
| +7% | +$4.08M |
|
348
Globe Life
GL
$13.9B
| $85.5M | 0.05% |
1,151,632
-220,103
| -16% | -$16.7M |
|
349
Vanguard S&P 500 ETF
VOO
$971B
| $85.3M | 0.05% |
300,975
+260,594
| +645% | +$70.1M |
|
350
Insulet
PODD
$11.6B
| $85.1M | 0.05% |
438,162
+37,449
| +9% | +$7.16M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.